Get the Stockscreener App
1.09
0.93%
0.01
Standard Biotools Inc stock is traded at $1.09, with a volume of 1.18M.
It is up +0.93% in the last 24 hours and up +2.35% over the past month.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
See More
Previous Close:
$1.08
Open:
$1.07
24h Volume:
1.18M
Relative Volume:
0.65
Market Cap:
$413.10M
Revenue:
$106.34M
Net Income/Loss:
$-74.66M
P/E Ratio:
-1.1474
EPS:
-0.95
Net Cash Flow:
$-46.12M
1W Performance:
-6.03%
1M Performance:
+2.35%
6M Performance:
-41.40%
1Y Performance:
-59.63%
1-Day Range:
$1.06
$1.17
1-Week Range:
$1.0501
$1.21
52-Week Range:
$0.99
$3.04
Standard Biotools Inc Stock (LAB) Company Profile
Name
Standard Biotools Inc
Sector
Industry
Phone
(650) 266-6000
Address
2 TOWER PLACE, SOUTH SAN FRANCISCO
Compare LAB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.09 | 413.10M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
131.69 | 228.39B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
101.24 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
373.30 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.49 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.87 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-27-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-16-24 | Initiated | TD Cowen | Buy |
| Apr-04-24 | Initiated | Jefferies | Buy |
| Jul-12-23 | Initiated | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Stock (LAB) Latest News
Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by Swiss National Bank - Defense World
What Will Standard BioTools Inc (NASDAQ: LAB) Be Like In 2025 - Stocks Register
Charles Schwab Investment Management Inc. Sells 112,434 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Bank of New York Mellon Corp Reduces Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools at KeyBanc Forum: Strategic Moves in Plasma Proteomics By Investing.com - Investing.com Canada
STANDARD BIOTOOLS INC. SEC 10-K Report - TradingView
Rhumbline Advisers Sells 10,975 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Casdin partners master fund acquires over $5.1 million in Standard BioTools stock - Investing.com India
Casdin Partners master fund buys $5.13 million in Standard BioTools stock By Investing.com - Investing.com South Africa
Casdin Partners master fund buys $5.13 million in Standard BioTools stock - Investing.com
Casdin partners master fund acquires over $5.1 million in Standard BioTools stock By Investing.com - Investing.com South Africa
Biochips Market Generated Opportunities, Future Scope 2025-2032 | PerkinElmer, Inc., Fluidigm Corporation, Illumina - openPR
Q1 Earnings Forecast for Standard BioTools Issued By KeyCorp - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Simply Wall St
ARK Investment Management LLC Lowers Stake in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools to Participate in Upcoming Investor Conferences -February 27, 2025 at 04:02 pm EST - Marketscreener.com
Standard BioTools (NASDAQ:LAB) Announces Quarterly Earnings Results, Hits Estimates - MarketBeat
Standard BioTools Inc. Faces Revenue Decline Amid Market Challenges - TipRanks
Standard BioTools cut to Neutral at KeyBanc on guidance - MSN
Standard BioTools to Participate in Upcoming Investor Conferences - The Manila Times
Standard BioTools downgraded to Sector Weight from Overweight at KeyBanc - TipRanks
Standard BioTools Sets March Investor Conference Schedule: What Financial Updates Might Be Revealed? - StockTitan
Standard BioTools Shares Fall After Downgrade From KeyBanc -February 27, 2025 at 01:59 pm EST - Marketscreener.com
Standard BioTools stock downgraded at KeyBanc (LAB:NASDAQ) - Seeking Alpha
Standard BioTools Inc. (NASDAQ:LAB) Q4 2024 Earnings Call Transcript - Insider Monkey
KeyBanc Downgrades Standard BioTools to Sector Weight From Overweight, Removes $4 Price Target - Marketscreener.com
KeyBanc cuts Standard BioTools stock rating on revenue concerns - Investing.com India
KeyBanc cuts Standard BioTools stock rating on revenue concerns By Investing.com - Investing.com South Africa
Standard BioTools Inc (LAB) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Standard BioTools: Q4 Earnings Snapshot - CTPost
Standard BioTools reports Q4 EPS (9c), consensus (3c) - TipRanks
Standard BioTools Reports 2024 Financial Results - TipRanks
Buy Rating for Standard BioTools: Balancing Challenges with Strategic Growth Initiatives - TipRanks
Standard BioTools: Q4 Earnings Snapshot -February 26, 2025 at 06:53 pm EST - Marketscreener.com
Earnings call transcript: Standard BioTools Q4 2024 misses forecasts, stock dips - Investing.com
Standard BioTools Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Standard BioTools Reports 2024 Financial Results and Strategic Outlook - TipRanks
Can Standard BioTools' Massive $90M Cost Cuts Offset Declining Revenue? - StockTitan
Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Fluidigm stock hits 52-week low at $1.17 amid market challenges By Investing.com - Investing.com South Africa
Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results -February 26, 2025 at 04:02 pm EST - Marketscreener.com
Fluidigm stock hits 52-week low at $1.17 amid market challenges - Investing.com
Shareholders in Standard BioTools (NASDAQ:LAB) have lost 66%, as stock drops 10.0% this past week - Yahoo Finance
Standard BioTools Inc (LAB) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Analysts review Standard BioTools Inc’s rating - Knox Daily
Standard BioTools (LAB) to Release Quarterly Earnings on Wednesday - MarketBeat
Market Cool On Standard BioTools Inc.'s (NASDAQ:LAB) Revenues Pushing Shares 28% Lower - Simply Wall St
Standard BioTools (NASDAQ:LAB) Stock Price Up 7.1%Here's What Happened - MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 2,960,169 Shares of Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard Biotools Inc Stock (LAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):